Optimising pharmacotherapy in older cancer patients with polypharmacy

OBJECTIVE: Polypharmacy is frequent among older cancer patients and increases the risk of potential drug‐related problems (DRPs). DRPs are associated with adverse drug events, drug‐drug interactions and hospitalisations. Since no standardised polypharmacy assessment methods for oncology patients exi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrijkorte, Elze, de Vries, Jennifer, Schaafsma, Ron, Wymenga, Machteld, Oude Munnink, Thijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063689/
https://www.ncbi.nlm.nih.gov/pubmed/31692151
http://dx.doi.org/10.1111/ecc.13185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063689/
https://www.ncbi.nlm.nih.gov/pubmed/31692151
http://dx.doi.org/10.1111/ecc.13185

Ejemplares similares